Read-Gene (WAR:RDG) Marketable Securities : zł5.51 Mil (As of Sep. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Read-Gene Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Read-Gene's Marketable Securities for the quarter that ended in Sep. 2023 was zł5.51 Mil.

Read-Gene Marketable Securities Historical Data

The historical data trend for Read-Gene's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Marketable Securities Chart

Read-Gene Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Marketable Securities

Get a 7-Day Free Trial

5.01

Read-Gene Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Marketable Securities	Get a 7-Day Free Trial															7.11	-	6.51	6.66	5.51

Read-Gene Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Read-Gene (WAR:RDG) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Read-Gene Marketable Securities Related Terms

Thank you for viewing the detailed overview of Read-Gene's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Read-Gene (WAR:RDG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003

Website

http://www.read-gene.com

Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene (WAR:RDG) Headlines

No Headlines